Syndros — CareFirst (Caremark)
nausea and vomiting associated with cancer chemotherapy
Initial criteria
- The patient has failed to respond adequately to a conventional antiemetic treatment (examples include dexamethasone, metoclopramide, olanzapine, prochlorperazine, and 5-HT3 receptor antagonists such as dolasetron, granisetron, or ondansetron)
Approval duration
6 months